Login | Register
 Username 
 Password 
 
Login

HIV ATLAS

HIV :: TUBERCULOSIS :: MALARIA

Primary links

  • HOME
    • About Us
    • Contact Us
  • CLASSIFIED BLOGS
  • JOBS
  • EVENTS
  • LINKS
  • DAILY WIRE
  • VIDEOS
  |  
Home Feed aggregator Sources

Featured Jobs

  • Dean - Indian Institute of Advanced Nursing, Chennai
  • Research Capacity Building Advisor, Haiti
  • Vacancy announcement in Afghanistan
  • Chief of Party- Kenya Public Health
  • Chief of Party/Technical Advisor, HIV-Haiti
  • DEPUTY CHIEF OF PARTY, RUSSIA
  • CHIEF OF PARTY, RUSSIA
  • Chief of Party, India
  • Chief of Party- Kenya
  • Namibia Department of Defense Program Lead

Events

  • 11th International Workshop on Adverse Drug Reactions & Co-Morbidities in HIV Philadelphia, PA, USA, 28 October 2009 (AEGiS)
  • Aids in Culture VI: Explorations in the Cultural History of AIDS International Conference. Mexico City, 9 - 14 December 2010
  • Sexual Health Conference in Bali, May 4-6
  • CBCP calls for summit on HIV-AIDS - ABS CBN News
  • ASEAN youth meet to map out HIV/AIDS prevention activities - Xinhua
  • Gujarat - Get togehter 3000 PLHAs at Capital of Gujarat
  • International Symposium on HIV & Emerging Infectious Diseases.
  • India NGO Awards 2009
  • HIV Congress 2010
  • January 2010 Free POZ Weekend Seminar in LA!

MEDSCAPE

Syndicate content Medscape Medical News Headlines
Latest medical news from Medscape
URL: http://www.medscape.com/welcome/news?src=rss
Updated: 9 hours 45 min ago

"Lenient" as Good as "Strict" Ventricular Rate Control in Permanent AF: RACE-2 Trial

10 hours 17 min ago
The standard heart-rate target of <80 bpm doesn't lead to better clinical outcomes and is harder to achieve than a target of <110 bpm, a prospective randomized trial found.
Heartwire
Categories: E-Groups

Statins Added to Standard Psoriasis Therapy May Improve Disease Severity

10 hours 20 min ago
Statin users with psoriasis showed a 64% reduction in psoriasis severity, whereas nonusers showed a 45% reduction in severity after the initiation of a new psoriasis medication.
Medscape Medical News
Categories: E-Groups

New Meta-Analysis: Routine Invasive Strategy Betters Selective Care for Non-ST-Elevation ACS

Mon, 03/15/2010 - 07:26
A more aggressive routine invasive strategy is clearly better than a conservative selective invasive strategy for all patients with non-ST-elevation acute coronary syndromes, a new meta-analysis shows. And the highest-risk patients had the most to gain, indicating that risk stratification is crucial, says the lead researcher.
Heartwire
Categories: E-Groups

Abdominal CT Exams May Reveal Patients at Higher Risk for Cardiovascular Disease

Mon, 03/15/2010 - 07:26
A small study of patients who have had both abdominal CT scans and coronary angiography found that abdominal aortic calcification is a predictor of obstructive coronary disease.
Heartwire
Categories: E-Groups

INVEST: Mortality Hazard With Lowest Blood Pressures in Diabetics With CAD?

Mon, 03/15/2010 - 07:26
Diabetic patients whose systolic blood pressure was lowered to 130 to 140 mm Hg had a better outcome than those with systolic pressures over 140. But reductions below 130 did not appear to offer any additional benefit and had a higher mortality rate in this retrospective analysis.
Heartwire
Categories: E-Groups

No Increased Atherosclerotic-Plaque Burden in Cops and Firefighters

Sun, 03/14/2010 - 21:46
The atherosclerotic-plaque burden among cops and firefighters is no higher than in a cohort of age-matched controls, suggesting that something else, possibly increased emotional and physical stress, is causing the increased risk of on-the-job cardiac-related events.
Heartwire
Categories: E-Groups

Nanoparticle Detonations May Be Able to Burn Vascular Plaques

Sun, 03/14/2010 - 21:46
Biophotonic destruction of plaques with laser-activated nanoparticles shows promise in early clinical studies.
Heartwire
Categories: E-Groups

Psoriasis "Firmly Established" as Risk Factor for CV Disease

Sun, 03/14/2010 - 21:46
Psoriasis patients should be considered at increased cardiovascular risk and prioritized for earlier medical risk-factor intervention for heart disease, the authors of a new study say.
Heartwire
Categories: E-Groups

ACCORD BP: Intensive BP Lowering Futile in Diabetics

Sun, 03/14/2010 - 17:30
The ACCORD BP study shows that there is no benefit to be gained from intensively lowering systolic blood pressure to less than 120 mm Hg in type 2 diabetics; for now, a goal of <140 mm Hg seems reasonable in this population, say the authors.
Heartwire
Categories: E-Groups

NAVIGATOR Off Course to Diabetes Prevention With Valsartan, Nateglinide

Sun, 03/14/2010 - 17:30
In a population with impaired glucose tolerance and CV disease or risk factors, the angiotensin receptor blocker had a slight effect and the short-acting insulin secretagogue had no favorable impact on progression to diabetes; neither drug prevented cardiovascular events.
Heartwire
Categories: E-Groups

ACCORD: Fenofibrate No Benefit to Statin Therapy in High-Risk Diabetic Patients

Sun, 03/14/2010 - 17:30
The findings do not support the use of combination fibrate-statin therapy to reduce cardiovascular risk in the majority of patients with type 2 diabetes who are at high risk for cardiovascular disease, according to the ACCORD investigators.
Heartwire
Categories: E-Groups

EVEREST II: Mitral-Clip Device Noninferior to Surgical Repair or Replacement

Sun, 03/14/2010 - 17:30
Much-anticipated results from EVEREST II show that the novel device--a percutaneous version of edge-to-edge mitral-valve repair--may be safer than traditional valve repair or replacement, with "noninferior" efficacy out to one year.
Heartwire
Categories: E-Groups

Antisense Inhibitor of ApoB Synthesis: A New Approach for Severe Hypercholesterolemia

Sun, 03/14/2010 - 05:01
The novel agent was associated with impressive reductions of LDL and Lp(a) in a trial in patients with homozygous FH.
Heartwire
Categories: E-Groups

Women More Likely to Be Referred for Cath

Sun, 03/14/2010 - 04:24
There appears to have been a paradigm shift in the way cardiologists refer to the cath lab, a new registry study suggests.
Heartwire
Categories: E-Groups

Fitness More Important Than Fatness for Thrombotic Risk in Firefighters

Sun, 03/14/2010 - 04:24
Despite looking fit and healthy, a third of firefighters examined in a new study were at high risk of a thrombotic event, and improving their fitness is more likely to reduce this risk than tackling excess body weight, say the researchers.
Heartwire
Categories: E-Groups

Abiomed Repairs Potentially Dangerous Computer Problem in AB5000 Circulatory-Support Devices

Sun, 03/14/2010 - 03:19
Abiomed is repairing some AB5000 circulatory-support devices as part of a class I recall triggered by computer problems that cause it to shut down without warning.
Heartwire
Categories: E-Groups

CDC Concerned About Spike in Mumps Cases in NY/NJ Hasidic Community

Sat, 03/13/2010 - 09:09
An ongoing outbreak of mumps in the Hasidic (Jewish) community in New York and New Jersey prompted the Centers for Disease Control and Prevention to issue a Health Advisory this week.
Medscape Medical News
Categories: E-Groups

Overweight, Obese Gain Greater Benefit From BP Lowering

Sat, 03/13/2010 - 04:04
The overweight and obese should be more aggressively treated with antihypertensive therapy than normal-weight individuals, because they will derive greater benefit, a new analysis of the PROGRESS study suggests.
Heartwire
Categories: E-Groups

NCCN Panel: Straight Talk With Compassion Urged for End-of-Life Cancer Care

Sat, 03/13/2010 - 03:57
Telling patients that they have cancer and/or that the end is near should be handled in an informative, compassionate, individualized manner.
Medscape Medical News
Categories: E-Groups

Adapalene-Benzoyl Peroxide Combination Gel Improves Symptoms of Acne Vulgaris

Sat, 03/13/2010 - 02:46
Adapalene-benzoyl peroxide gel is more effective than the individual components for the treatment of inflammatory acne, and it has a rapid onset of action.
Medscape Medical News
Categories: E-Groups
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • next ›
  • last »

RESOURCES

  • AEGiS
  • AIDS.gov
  • AIDS_ASIA
  • AIDS-INDIA
  • AIDSPORTAL.org
  • About.com
  • Aids-write.org
  • All Africa.com
  • CDC
  • Children & HIV
  • Clinical Care Options HIV
  • DailyMed
  • EATG
  • EBLING LIBRARY
  • Eldis-Jobs
  • Eldis.org
  • GNP Latest news
  • Google-Homophobia
  • Google-HIV Baby-sitting
  • Google HIV NEWS
  • Google MALARIA NEWS
  • Google TB NEWS
  • HIV Law Project
  • HIV Positive Dating
  • HIV Twinning News
  • Hivdatfla
  • Hivsnp
  • IAVI
  • IFANET-INDIA
  • IGIB/CSIR
  • DevNetJobs
  • Indeed.com
  • Iran HIV AIDS
  • Juju-HIV
  • Kaiser-Child health
  • Kaiser HIV/AIDS
  • Kaiser Malaria
  • Kaiser-Tuberculosis
  • Kaiser-U.S. HIV
  • Medical News-HIV
  • Medical News-TB
  • MEDSCAPE
  • Medsin Manchester
  • National AIDS Map
  • Nature Jobs
  • Nets at Harvard University
  • NIAID
  • NMAC
  • NIH.gov
  • NMPrev
  • OpenSource.org.in
  • Oxfam Jobs
  • Partners Zambia
  • Policy and Ethics
  • PozHealth
  • PubMed-HIV
  • PubMed-Malaria
  • RBM Topline Stories
  • SAATHII
  • Save The Children
  • Treatment Action Campaign
  • Tuberculous-Meningitis
  • Tuberculosis-Pulmonary
  • UKLug-HIV
  • UKLug-Tuberculosis
  • UNAIDS-JOBS
  • UNAIDS-SERVICE
  • UNICEF News
  • UNICEF Photo Essays
  • WHO
  • Women & HIV
Every 9½ minutes someone in the US is infected with HIV. Act Against AIDS. Get the facts: NineAndaHalfMinutes.org

ABOUT HIV ATLAS

A Social Media initiative that aims to Collect, Collate, Classify and Disseminate the information on HIV, TB & Malaria so that people living with HIV and the people working in the field can be on top of the information generating from more than 700 online and offline resources.

HIV ATLAS provides its users a unique way to be on top of information ranging from common living to funding, jobs, events and much more absolutely free of charge. We encourage Employers to post their Job opportunities in our featured Jobs cateogry to reach out to more than 40000 subscribers daily.

JOIN HIV ATLAS

HIV ATLAS welcomes content contributions and strongly encourages all sector participants to actively share their advertisements.

You can contribute and engage by:
- Creating your profile
- Posting your classified advertisements
- sharing information about Jobs, Events, Funding etc with us
- sharing information about any online resource you want us to include
- creating your resume for potential employers to have a look in.

NEWLETTER SUBSCRIPTIONS

Manage your newsletter subscriptions
Select the newsletter(s) to which you want to subscribe or unsubscribe.
  Copyright © 2004-2009 HIV ATLAS.org. All rights reserved. | Legal | Contact Powered by Halosys Technologies Inc.  

Disclaimer: This site contains HIV prevention messages that may not be appropriate for all audiences.